Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
Astria Therapeutics, a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, announced that it will present final results from the ALPHA-STAR Phase 1b/2 trial of navenibart in people living with hereditary angioedema (HAE) at the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific Meeting.
The meeting will take place November 6-10, 2025 in Orlando, Florida. The presentation will be given by Aleena Banerji, M.D.
Astria Therapeutics focuses on developing life-changing therapies for allergic and immunologic diseases.
Author's summary: Astria Therapeutics presents at ACAAI meeting.
More News
- SNAP Rules November 2025: Changes and eligibility criteria for food stamps updated
- Trump Administration Admits It Doesn’t Know Who Exactly It’s Killing in Boat Strikes
- The unexpected reaction of Tyreek Hill after the firing of Dolphins general manager Chris Grier
- Amazon’s newest streaming stick is missing a Spotify app.
- Jerry Jones needs to learn from Carlie Irsay-Gordon if he wants the Cowboys to win the Super Bowl